Adenosine Deaminase (ADA) Antibody

Este producto es parte de ADA - Adenosine Deaminase
Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Adenosine Deaminase (ADA) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx302692
tested applications
ELISA, WB, IHC, IF/ICC

Description

ADA Antibody is a Rabbit Polyclonal against ADA.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Adenosine Deaminase (ADA)
Host
Rabbit
Reactivity
Human
Recommended Dilution
WB: 1/500 - 1/5000, IHC: 1/20 - 1/200, IF/ICC: 1/50 - 1/200. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Tested Applications
ELISA, WB, IHC, IF/ICC
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P00813
Gene ID
100
OMIM
102700
Alias
Adenosine aminohydrolase
Background
Antibody anti-ADA
Status
RUO

Descripción

Adenosine deaminase (ADA) is an enzyme crucial in purine metabolism, responsible for catalyzing the irreversible deamination of adenosine and deoxyadenosine to inosine and deoxyinosine, respectively. ADA is predominantly found in lymphocytes, with high activity in tissues such as the thymus, spleen, and bone marrow. It is vital for the development and maintenance of the immune system, as its deficiency leads to the accumulation of toxic purine metabolites, which impair DNA synthesis and lymphocyte survival. Mutations in the ADA gene result in severe combined immunodeficiency (SCID), characterized by a lack of functional T, B, and NK cells. ADA is also widely studied as a marker of immune activation and inflammation in conditions like tuberculosis and rheumatoid arthritis. Therapeutic interventions for ADA deficiency include enzyme replacement therapy and gene therapy, both of which aim to restore immune function.

Related Products

EH1544

Human ADA(Adenosine deaminase) ELISA Kit

Ver Producto
EM1599

Mouse ADA(Adenosine deaminase) ELISA Kit

Ver Producto
ER1974

Rat ADA(Adenosine deaminase) ELISA Kit

Ver Producto